Skip to main content

HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, March 27, 2026 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis, is pleased to announce that wholesale cannabis products previously exported to Germany during the prior quarter have now been successfully released for sale in the German market.

The release follows completion of required import, quality control, and market release procedures for Germany’s regulated medical cannabis market. Following this milestone, the Company has accepted a reorder for additional wholesale product.

This milestone builds on HYTN’s previously announced strategic supply framework for Germany and further demonstrates the Company’s ability to execute within highly regulated international medical cannabis markets.

“The successful release of product into the German market is a significant commercial milestone,” said Elliot McKerr, Chief Executive Officer of HYTN. “It validates that our GMP platform meets the stringent requirements of one of the world’s most tightly regulated medical cannabis markets. The acceptance of a reorder is a positive indicator as we continue toward building recurring international revenue channels.”

HYTN believes the successful German market release of this shipment further validates the commercial progress reflected in its recent financial results and supports the Company’s strategy of expanding pharmaceutical-grade cannabis sales into highly regulated international markets

About HYTN Innovations Inc.

HYTN Innovations Inc. is a pharmaceutical company specializing in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids. The Company focuses on serving federally regulated markets by applying pharmaceutical-grade development, manufacturing, and quality systems. HYTN advances products to market by identifying regulated market opportunities and leveraging its integrated development and commercialization platform.

For more information contact:
Elliot McKerr
Chief Executive Officer
HYTN Innovations Inc.

HYTN Investor Relations:
1.866.590.9289
investments@hytn.life

The Canadian Securities Exchange (CSE) has not reviewed, approved, or disapproved the contents of this press release.

Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information relates to future events or future performance and is generally identifiable by the use of words such as “expect,” “intend,” “may,” “will,” “anticipate,” “believe,” and similar expressions, or by statements regarding matters that are not historical facts. Such statements are based on the Company’s current beliefs, assumptions, and expectations regarding future events and operating conditions.

This press release contains forward-looking information relating to, among other things: the successful release and sale of cannabis products in the German market; the acceptance and fulfillment of the reorder; the continuation and growth of commercial activity in Germany; and the Company’s ability to execute within highly regulated international medical cannabis markets.

Forward-looking information is based on certain assumptions, including, but not limited to: the assumption that all required regulatory approvals and processes will be maintained or obtained as expected; that product quality and supply will meet German market requirements; that customer demand will continue; and that the Company will have sufficient resources to fulfill orders. These assumptions are based on information currently available to the Company. Although management believes such assumptions to be reasonable, there can be no assurance that they will prove to be correct.

Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, events, or outcomes to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, without limitation: regulatory risks in Canada and Germany; delays or failures in import, quality control, or market release processes; changes in customer demand or reorder volumes; operational risks; supply chain disruptions; and financing and liquidity risks.

The forward-looking information contained in this press release is made as of the date hereof, and the Company does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Readers are cautioned not to place undue reliance on forward-looking information.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.